i-STAT in the ED | CHEST PAIN

ACCELERATE ANSWERS. ADVANCE CARE. FOR SUSPECTED ACS, YOUR ED NEEDS ANSWERs AT THE SPEED OF i-STAT

background image

i-STAT in the ED | CHEST PAIN

ACCELERATE ANSWERS. ADVANCE CARE. FOR SUSPECTED ACS, YOUR ED NEEDS ANSWERs AT
THE SPEED OF i-STAT

background image
background image
background image
presentation

i-STAT in the ED | CHEST PAIN

ACCELERATE ANSWERS. ADVANCE CARE. FOR SUSPECTED ACS, YOUR ED NEEDS ANSWERs AT THE SPEED OF i-STAT

The need to improve cardiac care is more relevant than ever. In today’s ed, the focus must remain on fast, accurate assessment and disposition of patients. for suspected acs, your ed needs answers at the speed of i-stat

COMPLEX

Evaluation Poses Diagnostic Challenges

Inclusive of many different complaints that may not be caused by acute myocardial infarction (AMI)

CRITICAL

Rapid Diagnosis of MI is Imperative

Time is muscle; delays can lead to loss of vital heart muscle and function.

solutions

the i-stat system: results within minutes, right within the care pathway

cardiac troponin i


advantages aligned to your ed priorities

  • Accelerating triage and disposition
  • Elevating the patient experience
  • Optimizing resource utilization
  • Standardizing workflows

Aids in the diagnosis of AMI*

Aids in the diagnosis of AMI*

basic metabolic panel hematocrit & hemoglobin

Obtain rapid results on creatinine and potassium levels

*Medical decision should not be based on a single i-STAT measurement.

WE BRING
FOCUSED EXPERTISE TO TROPONIN
TESTING IN THE
ED1

  • 15 YEARS OF EXPERIENCE IN TROPONIN TESTING
  • 1,300 US HOSPITALS
  • 5 MILLION TROPONIN TEST RUN ANNUALLY
  • COMMITTED TO COLLECTING LEARNINGS & SHARING BEST
    PRACTICES ACROSS HOSPITALS

we bring focused
expertise to troponin testing in the ed1

  • 15 years of experience in troponin testing
  • 1,300 us hospitals
  • 5 million troponin test run annually
  • committed to collecting learnings & sharing
    best practices across hospitals
background image
background image
background image
The Sympheos™ System The Sympheos™ System

WE BRING FOCUSED EXPERTISE TO TROPONIN TESTING IN THE ED1

  • 15 YEARS OF EXPERIENCE IN TROPONIN TESTING
  • 1,300 US HOSPITALS
  • 5 MILLION TROPONIN TEST RUN ANNUALLY
  • COMMITTED TO COLLECTING LEARNINGS & SHARING BEST PRACTICES ACROSS
    HOSPITALS

the path to success starts with i-stat in your ed

i-STAT cTnI IN THE ED

Integrate i-STAT early in the patient-care pathway.

  • Lab-quality Troponin results at the patient's bedside2
  • Accelerate care decisions for time-sensitive patients

Hs-cTn IN THE HOSPITAL

Utilize hs-assays for admitted patients.3

  • Re-baseline on core laboratory cTn assay for admitted patients
  • When multiple platform testing is conducted, it is important to indicate the methodology used on the laboratory report as well as the assay-specific 99th percentile
the value of poct
Testimonial Testimonial Testimonial

“Having the test result come back in real time at point of care allows us to make immediate decisions… If I have a positive troponin at triage, I now have identified a patient as high risk and they’re going to go down the MI pathway.”

Dr. W. Frank Peacock
Professor of Emergency Medicine
related topics
Gondulus Gondulus Gondulus

“Dr. Brandy Gunsolus, pathology utilization manager at Augusta University Medical Center, a large, Level One Academic medical center, describes why her lab continues to use i-STAT troponin to aid in rapid disposition of chest pain patients in the ED”

dr white dr white dr white

“Dr. Michael White, ED Medical Director, describes how i-STAT troponin is used in a hybrid use-model in conjunction with a lab-based hs-cTn assay”


dr hertner dr hertner dr hertner

“The value of point-of-care testing is maximized when used as early as possible in the patient encounter. Dr. George Hertner, Chief of Emergency Medicine, Memorial Health System, describes the impact of i-STAT troponin and CHEM8+ when performed in triage.”


accelerate answers. advance chest pain care

for your chest pain patients in the ed

References

  1. Data on File. Abbott Point of Care. 2019 hospital data. 200 beds or larger. 2020.
  2. Point-of-Care i-STAT Cardiac Troponin I for Assessment of Patients with Symptoms Suggestive of Acute Coronary Syndrome, Clinical Chemistry 52, No. 2, 2006 323
  3. Wu, Alan H.B., et al, Clinical Chemistry, 64:4, 645-655 (2018)

a leader in rapid point-of-care diagnostics.

©2024 Abbott. All rights reserved. Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.

This website is governed by applicable U.S. laws and governmental regulations. The products and information contained herewith may not be accessible in all countries, and Abbott takes no responsibility for such information which may not comply with local country legal process, regulation, registration and usage.

Your use of this website and the information contained herein is subject to our Website Terms and Conditions and Privacy Policy: US Citizens | Non-US Citizens. Photos displayed are for illustrative purposes only. Any person depicted in such photographs is a model. GDPR Statement (last updated: May 2018) |.

Not all products are available in all regions. Check with your local representative for availability in specific markets. For in vitro diagnostic use only. For i-STAT test cartridge information and intended use, refer to individual product pages or the cartridge information (CTI/IFU) in the i-STAT Support area.

Abbott - A Leader in Rapid Point-of-Care Diagnostics.